Ruxue Shi

2PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 14, 2026
WTAP stabilized by USP7 contributes to enzalutamide resistance in prostate cancer via mediating AKT m6A-modification.

Ruxue Shi, Kai Gu, Haichuan Li

|Jun 13, 2024
ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation.

Qingxia Hu, Junling Yin, Sijie Zhao

Pageof 1

Frequent Collaborators

2 joint publications

Qingxia Hu

2 joint publications

Shuhong Huang

1 joint publications

Junling Yin

1 joint publications

Sijie Zhao